Burkitt lymphoma risk after transplantation highlighted

By Lynda Williams, Senior medwireNews Reporter

Solid organ transplant recipients have a significant risk for developing Burkitt lymphoma (BL), US researchers have found.

Transplant recipients in the USA are 23 times more likely to develop BL than members of the general population, with an incidence of 10.8 cases per 100,000 person-years, say Sam Mbulaiteye (National Cancer Institute, Bethesda, Maryland, USA) and co-authors.

The team reviewed BL incidence in 203,557 solid organ recipients listed in the US Transplant Cancer Match Study of 1987 to 2009.

The incidence of BL peaked in solid organ recipients between 3 and 8 years after transplantation, contrasting with the sharp increase in risk for the virus-associated malignancies, diffuse large B-cell lymphoma and Kaposi sarcoma, 1 year after transplantation, the team reports in the American Journal of Hematology.

"This longer latency suggests that progression to BL occurs after chronic immunosuppression and chronic EBV [Epstein-Barr virus] infection," say the researchers. "Alternatively, the lower incidence of BL in the first few years after transplantation may reflect the negative impact of intense immunosuppression on progression to BL during that period."

Of note, the incidence of BL was significantly higher in patients who received their organ before the age of 18 years compared with at 35 years or older (incidence rate ratio [IRR]=3.49) and in liver or heart than kidney recipients (IRR=2.91 and 2.39, respectively), after adjusting for confounding factors.

By contrast, BL was less common in female than male recipients (IR=0.45) and in Black than White patients (IRR=0.33). Patients seropositive for EBV at baseline were also less likely to develop BL than seronegative patients (IRR=0.34).

The risk for BL was also reduced by treatment with azathioprine (IRR=0.56) and corticosteroids (IRR=0.48), the researchers say.

Mbulaiteye et al also found that 69% of 32 examined LB tumors were positive for EBV. "This suggests the presence of distinct BL entities, which may differ in etiology," they write.

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.


  1. Dolores Claesson Dolores Claesson United States says:

    Immune compromised individuals like AIDS patients, LYME patients and Asians with AIDS but no HIV infection might fall into this category and guess what ?  We see Burkitt's lymhoma there too !!!

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Innovative blood test boosts accuracy of lung cancer screening